期刊文献+

宫颈癌组织中拓扑异构酶Ⅱ、P-糖蛋白的表达及其临床意义 被引量:4

The Expression of TopoisomeraseⅡ and P-glycoprotein in Cervical Squamous Carcinoma and Their Clinical Significance
暂未订购
导出
摘要 目的 :探讨DNA拓扑异构酶Ⅱ (TopoisomeraseⅡ ,TopoⅡ )及P 糖蛋白 (P glycoprotein ,P gp)在正常宫颈组织、宫颈上皮内瘤变 (cervicalintraepithelialneoplasm ,CIN)和宫颈癌中的表达。方法 :采用免疫组化的方法对 18例正常宫颈组织、2 8例CIN及 5 8例浸润性宫颈癌进行TopoⅡ和P gp的检测。结果 :TopoⅡ在正常宫颈组织、CIN及宫颈癌中均有表达 ,但在CINⅢ和宫颈癌中表达水平高于正常组织和CINⅠ组。P gp在正常宫颈组织中无阳性表达 ,在CINⅠ、CINⅡ、CINⅢ组中表达水平明显高于浸润性宫颈癌组。TopoⅡ的表达与浸润性宫颈癌组织学分级无关 ,而P gp在低分化癌的阳性率明显低于中高分化癌。结论 :TopoⅡ是检测肿瘤细胞增殖的一种免疫标记物 ,其在宫颈癌中明显高表达 ,选择TopoⅡ抑制剂进行化疗有助于提高化疗效果。P Objective To investigate the expression of topoisomeraseⅡ(TopoⅡ) and P glycoprotein(P gp) in normal cervical squamous tissue,cervical intraepithelial neoplasm(CIN) and cervical squamous carcinoma.Methods Immunohistochemical method was used to detect the expression of TopoⅡ and P gp in 18 cases of normal cervical tissue,28 cases of CIN and 58 cases of invasive cervical carcinoma.Results Normal cervical tissue,CIN and invasive carcinoma all expressed TopoⅡ.And the positive expression in invasive cervical carcinoma and CINⅢ was higher than that in normal tissue and CINⅠ.There is no expression of P gp in normal tissue,and in CINⅠ,CINⅡ,CINⅢ P gp expressed higher than that in invasive cervical carcinoma. The expression of TopoII did not correlate with the differentiation,but the expression of P gp was lower in poorly differentiated carcinomas than that in well differentiated ones( P <0 05).Cordusions Topoisomerase Ⅱ is a useful proliferation marker in the detection of cervical squamous carcinoma.TopoⅡ was expressed highly in invasive cervical carcinoma and could be the target of anti tumor drugs,so TopoⅡ inhibitors should be selected to improve the efficiency of chemotherapy.The expression rate of P gp may not play an important rale in the drug resistance in cervical squamous carcinoma.
出处 《肿瘤防治杂志》 2002年第4期395-397,共3页 China Journal of Cancer Prevention and Treatment
基金 湖北省卫生厅资助项目 (WJ0 15 89)
关键词 宫颈癌组织 拓扑异构酶 P-糖蛋白 表达 免疫组织化学 cervix neoplasms DNA topoisomerase P glycoprotein immunohistochemistry
  • 相关文献

参考文献5

  • 1Bergman AM,Munch Petersen B,Jensen PB,et al.Collateral sensitivity to gemcitabine (2′, 2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin-and VM-26-resistant variants of human small cell lung cancer cell lines[].Biochemical Pharmacology.2001
  • 2Parajuli P,Yano S,Nishioka Y,et al.Therapeutic efficacy of a new topoisomerase Ⅰ and Ⅱ inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer[].Oncology Research.1999
  • 3Gibbons D,Fogt F,Kasznica J,et al.Comparison of topoisomerase Ⅱalpha and MIB-1 expression in uterine cervical squamous lesions[].Modern Pathology.1997
  • 4Ito K,Sasano H,Yabuki N,et al.Immunohistochemical study of Ki-67 and DNA topoisomerase Ⅱ in human endometrium[].Modern Pathology.1997
  • 5Li J,Xu LZ,He KL,et al.Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line[].Breast Cancer Research.2001

同被引文献47

  • 1刘宇,张幸平,陈晓品,陈鸿雁,徐曼,李圆圆.P糖蛋白在鼻咽癌放射治疗前后的表达及临床意义探讨[J].中华放射肿瘤学杂志,2004,13(3):243-244. 被引量:8
  • 2高国兰,万红英,黄传生,邹学森,陈文学.P-gp、GST-π、TS蛋白在宫颈癌中的表达及临床意义[J].临床肿瘤学杂志,2007,12(1):23-26. 被引量:11
  • 3万会平,汪华,喻燕敏.宫颈癌细胞受照后代生长特性及放射敏感性变化[J].临床肿瘤学杂志,2007,12(2):85-87. 被引量:1
  • 4连利娟.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,1999.335-344.
  • 5Ueda K, Cornwell M M, Gottesman M M, et al. The mdr1 gene, responsible for multidrug resistance, codes for P-glycoprotein[J]. Biochem Biophys Res Commun, 1986, 141 (3): 956-962.
  • 6Chiarugi V, Magnelli L, Gallo O, et al. Cox-2, iNOS and p53 as playmarkers of tumor angiogenesis[J]. Int J Mol Med, 1998,2 (6) :715-719.
  • 7Uefjii K, Ichikura T, Mochizuki H, et al. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer[J]. Clin Cancer Res, 2000,6(1) :135-138.
  • 8Tsujii M, Dubois R N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J]. Cell, 1995,83(3):493-501.
  • 9Fujita T, Matsui M, Takaku K, et al. Size and invasion dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas[J]. Cancer Res,1998,58(21) :4823-4826.
  • 10Murata H, Kawano S, Tsuji S, et al. Clyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma [J]. AM J Gastroenterology, 1999, 94 (2) :451 -455.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部